Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilly

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Genes, Chromosomes & Cancer|December 1, 1994
Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTCS Galiègue-Zouitina, M Collyn-d'Hooghe, C Denis, et al.
Leukemia|September 20, 2000
Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new clusterG Buchonnet, P Lenain, P Ruminy, et al.
Blood|November 1, 1992
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesP Fenaux, S Castaigne, H Dombret, et al.
American Journal of Hematology|November 1, 1996
Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemiaC Fruchart, B Lenormand, C Bastard, et al.
The New England Journal of Medicine|June 22, 1995
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study GroupH Dombret, C Chastang, P Fenaux, et al.
Leukemia|January 19, 2007
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomasP Bertrand, C Bastard, C Maingonnat, et al.
Leukemia|August 12, 2005
Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphomaF Jardin, P Ruminy, F Parmentier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
British Journal of Cancer|July 1, 1994
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'AdulteP Morel, B Dupriez, R Herbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimenA Bosly, B Coiffier, C Gisselbrecht, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Genes, Chromosomes & Cancer|December 1, 1994
Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTCS Galiègue-Zouitina, M Collyn-d'Hooghe, C Denis, et al.
Leukemia|September 20, 2000
Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new clusterG Buchonnet, P Lenain, P Ruminy, et al.
Blood|November 1, 1992
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesP Fenaux, S Castaigne, H Dombret, et al.
American Journal of Hematology|November 1, 1996
Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemiaC Fruchart, B Lenormand, C Bastard, et al.
The New England Journal of Medicine|June 22, 1995
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study GroupH Dombret, C Chastang, P Fenaux, et al.
Leukemia|January 19, 2007
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomasP Bertrand, C Bastard, C Maingonnat, et al.
Leukemia|August 12, 2005
Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphomaF Jardin, P Ruminy, F Parmentier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)E Lepage, C Gisselbrecht, C Haioun, et al.
British Journal of Cancer|July 1, 1994
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'AdulteP Morel, B Dupriez, R Herbrecht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimenA Bosly, B Coiffier, C Gisselbrecht, et al.
Pageof 16